BIO 2019 Notebook: M&A Soars, Lartruvo Lookback, BIO Vs. ASCO

 
• By Sue Sutter and Joseph Haas
  
Bio 2019 Notebook for Scrip
Lartruvo's market removal was a signal that the system works, former FDA official says
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip